End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non-Small-Cell Lung Cancer

被引:1
|
作者
Leung, Bonnie [1 ]
Wong, Selina K. [1 ,2 ]
Ho, Cheryl [1 ,2 ]
机构
[1] BC Canc, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
关键词
POPULATION-BASED-COHORT; EMERGENCY-DEPARTMENT VISITS; PALLIATIVE CARE; LITERACY; LANGUAGE; HOMECARE; SERVICES; IMPACT;
D O I
10.1200/OP.22.00110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Limited English-proficient (LEP) patients with non-small-cell lung cancer (NSCLC) may receive less palliative care services and more likely to receive aggressive end-of-life (EoL) care. Goals of this retrospective cohort study are to compare access to community palliative home care (CPHC), do not resuscitate (DNR) form completion, place of death, and health resource utilization at EoL between English-proficient (EP) and LEP patients with NSCLC in Vancouver, Canada. METHODS All patients with advanced NSCLC referred in 2016 and received medical care were included. Patients were classified as LEP if seen with a medical interpreter. Descriptive statistics and univariate and multivariate analyses were used to compare the outcomes between the two groups. RESULTS One hundred eighty-six patients were referred, 66% EP. Rates of CPHC referral and DNR form completion were the same for both groups (84% and 92%, P = 1.00). LEP patients received earlier access to CPHC (15 v 10 weeks before death, P5.039). Rates of ER visits within 6months and 30 days of death were 0.89 for EP patients and 0.7 for LEP patients, P =.374, and 0.1 for EP patients and 0.13 for LEP patients, P =.244. Hospitalization rates within 6 months and 30 days of death were 1.4 for EP patients and 1.59 for LEP patients, P =.640, and 0.67 for EP patients and 0.81 for LEP patients, P =.091. EP patients were more likely to have a home death (26% v 14%), whereas LEP patients died in acute care (23% v 14%) or a tertiary palliative care unit (24% v 19%). This was not statistically significant (P =.335). LEP patients had better median overall survival (8.5 v 5.4months, P <.001), but when controlled by age, mutation, and EP status, only receipt of palliative-intent systemic therapy was statistically significant. CONCLUSION EP and LEP patients with NSCLC have similar referral rates to CPHC, DNR form completion, and EoL health resource utilization. The measured EoL variables did not demonstrate significant disparities between EP and LEP patients.
引用
收藏
页码:728 / +
页数:10
相关论文
共 50 条
  • [41] Efficacy of Vinorelbine Monotherapy as Third- or Further-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Kang, Hyun
    Kim, Ju Ock
    Jung, Sung Soo
    Park, Hee Sun
    Chung, Chaeuk
    Park, Dongil
    Lee, Jeong Eun
    ONCOLOGY, 2019, 97 (06) : 356 - 364
  • [42] Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy era
    Apter, Lior
    Moser, Sarah Sharman
    Gazit, Sivan
    Chodick, Gabriel
    Hoshen, Moshe
    Greenberg, Dan
    Siegelmann-Danieli, Nava
    ONCOLOGIST, 2024,
  • [43] Performance Status and Resource Utilization in Patients Receiving Palliaitve Care with Stage IV Non-Small Cell Lung Cancer
    Rayburn, J.
    Wilshire, C.
    Gilbert, C.
    Weerasinghe, R.
    Louie, B.
    Aye, R.
    Farivar, A.
    Vallieres, E.
    Gorden, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S695 - S696
  • [44] Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma
    Chang, Chia-Ling
    Hsieh, Min-Shu
    Shih, Jin-Yuan
    Lee, Yi-Hsuan
    Liao, Wei-Yu
    Hsu, Chia-Lin
    Yang, Ching-Yao
    Chen, Kuan-Yu
    Lee, Jih-Hsiang
    Ho, Chao-Chi
    Tsai, Tzu-Hsiu
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [45] The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer
    McGee, Sharon F.
    Zhang, Tinghua
    Jonker, Hannah
    Laurie, Scott A.
    Goss, Glen
    Nicholas, Garth
    Albaimani, Khalid
    Wheatley-Price, Paul
    CLINICAL LUNG CANCER, 2018, 19 (01) : E91 - E99
  • [46] Hospice in End-of-Life Patients With Cancer: Does It Lead to Changes in Nonhospice Health Care Utilization After Stopping Cancer Treatment?
    Breitkopf, Carmen Radecki
    Stephens, Elisabeth K.
    Jatoi, Aminah
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2014, 31 (04) : 392 - 395
  • [47] Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States
    Zhang, Xinke
    Beachler, Daniel C.
    Masters, Elizabeth
    Liu, Frank
    Yang, Mo
    Dinh, Jade
    Jamal-Allial, Aziza
    Kolitsopoulos, Francesca
    Lamy, Francois-Xavier
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (02) : 255 - 265
  • [48] Spine Metastasis Is Associated with the Development of Brain Metastasis in Non-Small-Cell Lung Cancer Patients
    Cha, Hyung-Keun
    Ryu, Woo-Kyung
    Lee, Ha-Young
    Kim, Hyun-Jung
    Ryu, Jeong-Seon
    Lim, Jun-Hyeok
    MEDICINA-LITHUANIA, 2024, 60 (01):
  • [49] Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non-Small-Cell Lung Cancer
    Liang, Wenhua
    Zhang, Li
    Jiang, Gening
    Wang, Qun
    Liu, Lunxu
    Liu, Deruo
    Wang, Zheng
    Zhu, Zhihua
    Deng, Qiuhua
    Xiong, Xinguo
    Shao, Wenlong
    Shi, Xiaoshun
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (08) : 861 - +
  • [50] Surgical outcomes and prognosis of non-small-cell lung cancer in patients with chronic lung diseases: a retrospective analysis
    Choi, Soohwan
    Park, Jaekil
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (02) : 357 - 364